Kalanchoe tubiflora extract inhibits cell proliferation by affecting the mitotic apparatus
© Hsieh et al.; licensee BioMed Central Ltd. 2012
Received: 26 March 2012
Accepted: 31 August 2012
Published: 10 September 2012
Skip to main content
© Hsieh et al.; licensee BioMed Central Ltd. 2012
Received: 26 March 2012
Accepted: 31 August 2012
Published: 10 September 2012
Kalanchoe tubiflora (KT) is a succulent plant native to Madagascar, and is commonly used as a medicinal agent in Southern Brazil. The underlying mechanisms of tumor suppression are largely unexplored.
Cell viability and wound-healing were analyzed by MTT assay and scratch assay respectively. Cell cycle profiles were analyzed by FACS. Mitotic defects were analyzed by indirect immunofluoresence images.
An n-Butanol-soluble fraction of KT (KT-NB) was able to inhibit cell proliferation. After a 48 h treatment with 6.75 μg/ml of KT, the cell viability was less than 50% of controls, and was further reduced to less than 10% at higher concentrations. KT-NB also induced an accumulation of cells in the G2/M phase of the cell cycle as well as an increased level of cells in the subG1 phase. Instead of disrupting the microtubule network of interphase cells, KT-NB reduced cell viability by inducing multipolar spindles and defects in chromosome alignment. KT-NB inhibits cell proliferation and reduces cell viability by two mechanisms that are exclusively involved with cell division: first by inducing multipolarity; second by disrupting chromosome alignment during metaphase.
KT-NB reduced cell viability by exclusively affecting formation of the proper structure of the mitotic apparatus. This is the main idea of the new generation of anti-mitotic agents. All together, KT-NB has sufficient potential to warrant further investigation as a potential new anticancer agent candidate.
The mitotic spindle is a complex molecular scaffold that mediates proper sister-chromatid segregation during mitosis and is essential in maintaining genomic integrity of daughter cells. In animal cells, thus far two major pathways have been identified in mitotic spindle assembly. First, the mitotic centrosomes function as microtubule-organizing centers (MTOCs) , directing spindle assembly from spindle poles through the regulation of nucleating microtubules . The second pathway is dependent on a RanGTP gradient mediated by Aurora A, which regulates spindle assembly [3, 4]. The chromosomal passenger complex (CPC) generates spindle assembly in the absence of a RanGTP gradient [5, 6]. Disruption of these pathways and disruption of the mitotic spindle will activate the spindle assembly checkpoint, causing mitotic arrest and cell death .
Compounds that target microtubule assembly are often very promising as anti-cancer medication. Vinca alkaloids and taxanes, for example, are administered against both solid tumors and haematological malignancies [7–9]. Many of these compounds were originally isolated from a variety of marine organisms or botanicals [10–12]. Microtubule-targeting drugs are classified into two groups, microtubule-destabilizing agents and microtubule stabilizing agents [13, 14]. Both microtubule -destabilizing and -stabilizing agents inhibit cell proliferation by binding to tubulin, altering microtubule dynamics, and disrupting the mitotic spindle. Cancer cells are generally more susceptible to tubulin binding agents compared to normal cells . Since microtubules are present in cells that are in interphase or undergoing mitosis, these microtubule targeting agents not only disrupt mitotic spindle formation but they can also disrupt the microtubule network. The microtubule network mediates important cellular processes during interphase, which include cellular migration and intracellular transport. Disruption of the microtubule network can cause a diverse range cytotoxic effects .
Recently, a new generation of anti-mitotic agents that target kinesins and mitotic kinases, such as Eg5, Aurora kinase and polo-like kinase, were developed as putative anti-cancer medications [17, 18]. Eg5 is a kinesin motor that localizes to the centrosomes and MT asters during prophase  and is required for centrosome separation as well as bipolar spindle assembly [20, 21]. The aurora kinase family is crucial for the progression of cells from mitosis to cytokinesis [22–25]. Aurora A localizes to spindle poles and functions in centrosome maturation, separation and spindle bipolarity [26, 27]. Aurora B is the enzymatically active member of the CPC, which localizes along the chromosome arms and at the centromeres during prophase. It is concentrated at the inner centromere region from prometaphase to metaphase and transfers to the spindle midzone, cell cortex and midbody during late mitosis and cytokinesis [25, 28]. The CPC is essential both for the assembly and stability of the bipolar mitotic spindle . Inhibition of Aurora B and other components of CPC causes mitotic catastrophe [29–32], indicating that CPC may be involved in both mitotic spindle assembly pathways.
Kalanchoe is a genus of the Family Crassulaceae. Various species of Kalanchoe are often referenced in folklore, and commonly used in traditional medicine worldwide for the treatment of fever, abscesses, bruises, contused wounds, coughs, skin diseases, infections, hypertension, rheumatism and inflammation [33–36]. Kalanchoe species are also used by the Kerala tribes for treating cancer symptoms . A variety of bufadienolide compounds were isolated from various Kalanchoe species, which show strong anti-tumor promoting activity [38–43]. Kalanchoe tubiflora (KT), due to its wide variety of potential biological activities, was selected for this study. KT is one of the most common medicinal plants used for wound healing in Southern Brazil. The traditional uses of KT in wound healing coincide with results from systematic biological assays . Here we show that an n-BuOH-soluble fraction of KT has anti-proliferative activity, which is due to the induction of multi-polar spindles and chromosomal misalignment of mitotic cells. These abnormal mitotic events lead to mitotic catastrophe, a desirable effect of a cancer therapeutic drug.
All reagents were purchased from Sigma unless otherwise stated. The primary antibodies were used as followed: anti-alpha tubulin (mouse mAb B512, 1:2000; Sigma, Taiwan); anti-Aurora A polyclonal antibody (1: 500, Cell signaling, Taiwan); anti-phospho-Histone 3 polyclonal antibody (1: 500, Upstate, Taiwan).
Human lung carcinoma (A-549), human bladder papillary transitional cell carcinoma (BFTC905), human breast carcinoma (MCF-7), human larynx Epidermoid carcinoma (HEp-2), human uterus sarcoma (MED-SA) and HeLa cells were purchased from the Food Industry Research and Development Institute (Hsinchu, Taiwan). Cells were grown, according to supplier instructions, in media supplemented with 10% fetal bovine serum (FBS). Cells were maintained at 37°C in a humidified atmosphere of 5% CO2.
The percentage of growth inhibition was determined by the MTT cell proliferation/viability assay. A total of 2000 cells/well were seeded onto a 96-well plate for 16 h. Cells were treated with various concentrations of KT-NB (25 μg/ml, 12.5 μg/ml, 6.25 μg/ml, 3.125 μg/ml, and 1.5625 μg/ml) and incubated for an additional 3 days at 37°C. The MTT assay was performed in triplicate. Subsequently, the test solutions were removed and replaced with culture medium containing 500 μg/ml of MTT (Thiazolyl blue formazan, Sigma, Taiwan) for an additional 4-6 h. The supernatant was aspirated, and 200 μl of DMSO was added to the wells to dissolve any precipitate present. The optical density (OD) values were measured in an ELISA reader (SUNRISE, TECAN, Switzerland) at a wavelength of 570 nm. The mean and standard deviation of each group were calculated. The OD reading of every group was first subtracted by a blank (background) control. Relative survival rate = [OD (treatment groups)/OD (negative control)] x 100.
Cell mobility was assessed using a wound-healing assay. A-549 cells were seeded in six-well plates for 24 h. Confluent monolayer cells were scratched by a 200 μl pipette tip and then removed by washing the cells with serum-free medium to clear cell debris and suspension cells. Migration of cells into the wound was observed at different time points. Cells that migrated into the wounded area or cells with extended protrusion from the border of the wound were visualized and photographed under an inverted microscope.
Cells were treated with KT-NB or DMSO and harvested at 24, 48, 72 h. Floating and adherent cells were collected and fixed in cold 70% ethanol at 4°C overnight. After washing, cells were treated with RNase and stained with Propidium Iodide (PI) for 1 h in the dark at room temperature. Flow cytometric analysis was performed by using a FACScalibur flow cytometer (Becton Dickinson). Cell cycle distribution was analyzed using Cell Quest software (Becton Dickinson). Each experiment was conducted three times.
For immunostaining, cells were fixed in 4% paraformaldehyde in PBS buffer for 10 min at room temperature. The cells were permeabilized in 0.1% Triton X-100 in PBS for 5 min and then rinsed in PBS. Cells were blocked for 30 min at room temperature in PBS + 10% FBS. Antibody incubations were performed in PBS for 1 h, followed by four 10-min washes in PBS at room temperature. DNA was stained with 0.1 mg/ml DAPI for 5 min at room temperature and rinsed with PBS. Slides were mounted in Vectashield mounting medium (Vectra) and sealed using nail varnish.
Images were performed using a Zeiss Axiovert 200 M microscope controlled by MetaMorph Software. Image stacks were deconvolved and quick-projected. The images were processed using Adobe Photoshop.
Aurora B is required for stability of the bipolar mitotic spindle  and functions through the phosphorylation of histone H3 on Ser10 and Ser28 in prophase. Our results indicated that KT-NB treated cells also did not exhibit altered levels of Histone H3 phosphorylation (Figure 6B). Immunofluorescence analysis of α-tubulin and γ-tubulin revealed that the microtubule organization and centrosome number were normal in cells treated with KT-NB in interphase (data not shown). Taken together, these results suggested that KT-NB treatment induced multipolar spindles but did not interfere with the recruitment of essential components necessary for functional spindle poles, nor did it disrupt the microtubule network in interphase cells.
Medicinal plants are an important source for the potential development of effective anticancer agents . In fact, more than half of the today’s anticancer drugs were originally synthesized from natural products and their derivatives. In the present study, we found that extracts from Kalanchoe tubiflora (KT), exhibited significant anti-proliferative effects against a variety of human cancer cell lines.
Majority of the effective anti-cancer or antibiotic concentrations of plant extracts are greater than 100 μg/ml [45, 46]; however, in our study, cell proliferation was inhibited by 48 h treatment with 6.75 μg/ml KT-NB, and the viability was less than 50% after a 72 h exposure. KT-NB does affect normal diploid human cells that are dividing but much less efficiently than most of the cancerous cell lines we tested. Therefore, KT-NB may be a highly effective candidate as a future anti-cancer drug.
Drugs based on natural products that bind to tubulin or microtubules remain an important component in chemotherapy. Anti-mitotic agents inhibit cell proliferation by suppressing microtubule dynamics ; however, based on immunofluorescence staining images, we found that KT-NB did not disrupt the microtubule organization in interphase or spindle formation during mitosis, indicating that it is not a microtubule destabilizing agent. . Our results also showed that KT-NB, which did not lead to the formation of parallel microtubule alignment or packed bundles of microtubules, is not a microtubule stabilizing agent either . Rather than acting on microtubule dynamics, we found that KT-NB induces multipolar spindles and perturbs accurate mitosis.
Centrosomes increase both in size and in microtubule-capacity in late G2 phase of the cell cycle. Aurora A, by recruiting pericentriolar material (PCM) and interacting with the Ran-TPX2 pathway, is required for the maturation of centrosomes and mitotic-spindle assembly respectively [3, 49]. It was noted that depletion of TPX2 from Xenopus egg extracts results in the formation of less compact spindles . In vertebrate cells, depletion of TPX2 using RNAi also caused the formation of multipolar spindles ; however, inhibition of Aurora A activity results in monopolar spindles . Our immunostaining results showed that localization of Aurora A was not disrupted by KT-NB. Since we did not observe a high level monopolar spindles, an effect common with Aurora A inhibitors, it is also unlikely that KT-NB inhibits Aurora A activity.
Some of the KT-NB-treated cells showed normal bipolar spindles with two centrosomes in mitosis. It was noted that a few cells with more than two centrosomes could assemble almost bipolar spindles (Figure 7B). With KT-NB treatment, it did not matter whether spindles were formed by the normal two centrosomes or by extra centrosomes, as more than half of the cells with bipolar spindles failed to exhibit properly aligned chromosomes at the metaphase plate. Although, chromosomal misalignment can result from the suppression of microtubule dynamics by a stabilizing poison, such as taxol , as discussed previously, this is an unlikely mechanism for KT-NB.
The failure of non-bipolar attachment corrections during the stochastic attachment process in prometaphase, is another possibility for chromosomal misalignment. Aurora B, the enzymatic member of CPC, destabilizes the non-bipolar microtubule-kinetochore attachments by phosphorylating several microtubule capture factors on the kinetochore [52–54]. To examine if the misaligned chromosome in KT-NB treatment was due to the inhibition of Aurora B kinase, we analyzed the histone H3 phosphorylation levels. In prophase, the CPC localizes to the chromosome arms where it phosphorylates histone H3 on Ser10 and Ser28 . Phosphorylation of histone H3 was not affected in KT-NB treated cells (Figure 6B).
Plk is a central regulator of the cell cycle, playing crucial roles in mitotic events, including activation of CDC25c phosphatase, regulation of microtubule nucleation, centrosome maturation and kinetochore assembly [55, 56]. To ensure the accuracy of these processes, plk1 activity is subjected to complex regulation. It is activated at mitotic entry by Aurora A kinase and its adapator BORA, which phosphorylate plk1 in its T-loop [57, 58]. Plk1 is also activated by Aurora B kinase at centromeres, and that is ccrucial for polo function in regulating chromosome dynamics in prometaphase . In our study, monopolar spindles were not observed in KT-NB treated cells. Two other possible targets of KT-NB are CENP-E and Mps1. CENP-E is a plus end-directed motor protein that has a pivotal role in mitosis. It stabilizes the interaction between microtubules and kinetochores of the mitotic spindle  and regulates the mitotic checkpoints by modulating the function of BuBR1 . Complete inhibition of CENP-E leads to defective mitosis with unaligned chromosomes and apoptosis . Mps1 was originally discovered in a yeast genetic screen for mutants producing monopolar spindle . It is a conserved multi-functional kinase that plays roles in the SAC and chromosome bi-orientation . Some small-molecular inhibitors of Mps1 were developed in 2010 . Chemical inhibition of Mps1 leads to chromosome misalignment and increases the frequency of multipolar mitoses .
David Pellman’s group used live cell images to study the fate of cells with extra centrosomes in 2009 . According to their study, most of progeny of multipolar cells died or arrested regardless of whether the cells were mono- or poly-nucleated. It will be interesting to use live cell images in the future to reveal the fate of KT-NB treated cells.
Targeting of mitotic cells is one of the bases of therapy for patients with multiple types of solid tumors. Some antimitotic agents, taxanes or vinca alkaloids, affect both dividing and nondividing cells. An essential characteristic of the ideal new generation of antimitotic agents is to target dividing cells but not non-dividing cells. As most cancer cells have faster dividing rates, these drugs target cancer cells preferentially. Potentially then, perturbing the mitotic apparatus by KT-NB may be used to more efficiently target rapidly proliferating cancer cells.
Here we report that KT-NB is a promising anti-cancer agent candidate. Further in vivo research will be needed to determine the effectiveness of KT-NB as an actual anti-cancer compound. Unlike microtubule binding agents, KT-NB inhibits cell proliferation and reduces cell viability by two mechanisms: first, by inducing multipolarity; second, by disrupting chromosome alignment during metaphase. Both mechanisms disrupt mitotic progression and inhibiting cell proliferation. The underlying mechanism of KT-NB is complicated and unclear. Further research involving the identification and isolation of pure compounds that parallel the phenotypes observed in KT-NB treated cells will be necessary to determine the cellular targets of KT-NB.
We like to thank Mar Carmena and Ji-Hshiung Chen for their critical reading of the manuscript. We also thank Tang K. Tang for providing image systems. Work in CJC’s laboratory was funded by the National Science Council, Taiwan.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.